Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study
AA Sherbini, JM Gwinnutt, KL Hyrich… - …, 2022 - academic.oup.com
Objectives To estimate prevalence rates and identify baseline predictors of adverse events
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study
AA Sherbini, JM Gwinnutt, KL Hyrich… - Rheumatology …, 2022 - pubmed.ncbi.nlm.nih.gov
Objectives To estimate prevalence rates and identify baseline predictors of adverse events
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
[HTML][HTML] Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study
AA Sherbini, JM Gwinnutt, KL Hyrich… - Rheumatology …, 2022 - ncbi.nlm.nih.gov
Objectives To estimate prevalence rates and identify baseline predictors of adverse events
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study
A Sherbini, J Gwinnutt, K Hyrich… - Rheumatology …, 2021 - research.manchester.ac.uk
Objectives To estimate prevalence rates and identify baseline predictors of adverse events
(AEs) over the first year of treatment in patients with rheumatoid arthritis (RA) starting …
(AEs) over the first year of treatment in patients with rheumatoid arthritis (RA) starting …
Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study.
AA Sherbini, JM Gwinnutt, KL Hyrich… - Rheumatology …, 2022 - europepmc.org
Objectives To estimate prevalence rates and identify baseline predictors of adverse events
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
[PDF][PDF] Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study
AA Sherbini, JM Gwinnutt, KL Hyrich… - …, 2022 - academic.oup.com
Objectives To estimate prevalence rates and identify baseline predictors of adverse events
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study
AA Sherbini, JM Gwinnutt… - Rheumatology, 2022 - keele-repository.worktribe.com
OBJECTIVES: To estimate prevalence rates and identify baseline predictors of adverse
events (AEs) over the first year of treatment in patients with RA starting MTX. METHODS …
events (AEs) over the first year of treatment in patients with RA starting MTX. METHODS …
Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study.
AA Sherbini, JM Gwinnutt, KL Hyrich… - …, 2022 - search.ebscohost.com
Objectives To estimate prevalence rates and identify baseline predictors of adverse events
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study.
AA Sherbini, JM Gwinnutt, KL Hyrich… - Rheumatology …, 2022 - europepmc.org
Objectives To estimate prevalence rates and identify baseline predictors of adverse events
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
(AEs) over the first year of treatment in patients with RA starting MTX. Methods Data came …
[PDF][PDF] Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study
AA Sherbini, JM Gwinnutt… - Rheumatology, 2022 - keele-repository.worktribe.com